cell motility compared to noninvasive cancer cells. 2 Thus, cell migration could be a novel therapeutic target for cancer metastasis.
With regards to the mechanism of cell migration, the cytoskeleton has long been proposed to generate the driving force. Recently, however, it has been suggested that ion/water transport proteins are indispensable for cell migration, and that water flow due to the osmotic gradients generated by localized ion transport across the plasma membrane can also be the driving forces. Moreover, the osmotic gradient of the extracellular space influences cell migration by regulating ion/water transport proteins. 3 Thus, cell migration has begun to be studied from the point of view of cell volume regulation. 4 
| I ON HOMEOS TA S IS IN CELL VOLUME MAINTENAN CE
The plasma membrane has low permeability to negatively charged macromolecules that abound inside cells, whereas it is highly permeable to water because of the presence of aquaporins (AQPs).
Thus, even under steady-state conditions, cells are threatened by osmotic swelling due to the entrance of ions and water. However, cells are practically impermeable to sodium ions (Na + ) because of the low permeability of the membrane to Na + and because of active outward transport of Na + through Na + -K + -ATPase. In addition, potassium ions (K + ) leak outwardly through K + channels in accordance with the chemical potential gradient, which generates a negative charge inside cells that is followed by efflux of chloride ions (Cl − ). These ion transport proteins enable cells to keep intracellular ion concentrations lower than extracellular ion concentrations and to avoid osmotic cell swelling. 5 Thus, ion homeostasis achieved by the regulation of ion channels and transporters is crucial for cell volume regulation, even under steady-state conditions ( Figure 1 ). Furthermore, these proteins have been proposed to be involved in many types of cellular activities accompanied by cell volume changes such as migration, inflammation, proliferation, and cell death. 5 
| VOLUME REG UL ATI ON IN CELL MIG R ATION

| General mechanisms of cell migration
The initial step of cell migration is polarization along the axis of movement. Migration is achieved through a repeated cycle of protrusion of the leading edge and retraction of the rear part of the cell. 4 As a driving force of migration, the cytoskeleton has long drawn attention. In the process of cell migration, actin polymerization with the production of motile force for protrusion occurs predominantly at the leading edge, whereas myosin II associates with existing actin filaments to generate the force for rear retraction. 6 In fact, it has been suggested that the suppression of cancer cell migration by inhibition of actin polymerization could be an anticancer therapeutic target. 
| Role of ion/water transport systems in cell migration
Work from recent years provides evidence that cell volume regulation by ion/water transport is indispensable for efficient cell migration. Before giving an overview of the transport proteins involved in cancer cell migration, we will present the mechanisms of cell migration driven by water flow inside cells in this section.
| Cell migration by osmotic water flow
The relationship between osmotic volume change and cell motility was proposed in the 1980s. Oster and Perelson proposed that not actin polymerization but hydrostatic pressure generated by osmotic water flow is the driving force of the elongation of the acrosomal process in the sperm of Thyone, a sea cucumber. 7 Despite the implications of osmotic/hydrostatic pressure in cell motility, few studies have focused on it. In 1994, however, it was reported that cell migration is attenuated by extracellular hypertonicity in mammalian cells; hypertonic cell shrinkage was proposed to inhibit local volume gain, generates a negative membrane potential (ΔΦ = −40 to −100 mV). 5 The solid line indicates the major flow of ions, and the dotted line indicates the minor flow of ions. AQP, aquaporin which would facilitate cell migration. 8 Moreover, it was reported that cells move to regions with lower solute concentrations, which means that the extracellular solute gradient itself could be a driving force of cell migration. 9 From around this time, the relationship between water flow and cell migration has become the subject of much interest. Localized volume gain by water influx has been reported, and it has been suggested that the water influx is mediated by AQPs, which localize to the leading edges of migrating cells. 10 The importance of cell volume regulation is evident, especially in osmotic stress responses. Osmotic stress results from the difference between intracellular and extracellular osmolality and causes the compulsive water influx/efflux followed by cell swelling/shrinkage. Under osmotic stress-induced cell volume perturbation, cells undergo volume recovery processes called regulatory volume decrease (RVD) and regulatory volume increase (RVI) by actively transporting ions. 5 In the process of cell migration, it has been suggested that RVI facilitates protrusion of the leading edge and that RVD contributes to rear retraction.
In fact, ion/water transport proteins involved in RVD or RVI show different distributions during migration, which could generate localized osmotic gradients and subsequent volume changes for protrusion of the leading edge and retraction of the rear end. 4 Thus, osmotic water flow itself generated by ion transport could assist cell migration ( Figure 2 ).
Recently, this kind of cell migration has been studied from the point of view of cancer metastasis. Interestingly, metastatic breast cancer cells can migrate in a confined tube even under conditions of actin polymerization suppression, whereas the inhibition of Na + -H + exchanger 1 (NHE1) or AQP5 suppresses this type of cancer cell migration; moreover, changes in the extracellular osmolality affects the localization of NHE1, which eventually changes the direction of migration. 3 These observations suggest that osmotic water flow itself could be a driving force for cell migration, and the transport proteins concerned could be affected by changes in extracellular osmolality.
| Regulation of ion transport proteins under osmotic stress
As shown above, osmotic stress could change the localization or activity of ion/water transport proteins. It is important to elucidate the upstream regulation mechanisms of ion/water transport proteins to confirm the involvement of not only ion/water transport itself but also volume regulation systems in cell migration. The other mechanism for the regulation of ion/water transport proteins under osmotic stress is kinase-dependent signal transduction, such as that through the stress-induced mitogen-activated protein kinase (MAPK) pathway and the with-no-lysine kinase (WNK)-STE20/ SPS1-related proline/alanine-rich kinase (SPAK)/oxidative stress-responsive kinase 1 (OSR1) pathway (WNK-SPAK/OSR1 pathway), which change the activity or localization of ion transport proteins.
5,16
The MAPK pathway is activated by a wide variety of biological, chemical, and physical stimuli, including osmotic stress, and induces physiological processes, such as proliferation, survival, migration, and cell death. Mitogen-activated protein kinase signaling is composed of 3-layered kinase cascades including MAP3Ks, MAP2Ks, and MAPKs from upstream to downstream. Among MAPKs, ERK1/2, p38 MAPK, and JNK have been well investigated in the context of osmotic stress responses. These 3 MAPKs change their activity under osmotic stress, and play multiple roles in volume recovery. 16 These MAPKs have already been suggested to be involved in cell migration through the cytoskeleton and adhesion. 17 It is possible that these MAPK pathways regulate ion/water transport proteins in the process of cell migration.
In fact, NHE1, which is crucial for cell motility, is regulated by p38
MAPK or JNK in some species. 4 18 In fact, WNK1 is necessary for the homing of T cells because it activates migration. 19 Furthermore, glioma cells show higher WNK1, OSR1, and NKCC1 activity than other types of cells, which likely facilitates their migration. 20 As a common regulator of these kinases, apoptosis signal-regulating kinase 3 (ASK3), one of the stress-responsive MAP3Ks, plays an important role in osmotic stress responses. 21, 22 It uniquely responds to osmotic stress in rapid, bidirectional, and reversible manners, and proper changes in its activity are necessary for RVD and RVI. 22, 23 It is possible that ASK3 contributes to cancer cell migration through volume regulation.
In fact, metastatic osteosarcoma cells show high expression of ASK3 compared to nonmetastatic ones, 24 and the overexpression of ASK3 in prostate cancer cells promotes metastasis. 25 Furthermore, metastatic melanoma cells shows high expression of ASK3 compared to nonmetastatic melanoma cells, and patients with high expression of ASK3 in tumor tissues have high mortality ( Figure 3 ).
Thus, the regulation of cell volume by the MAPK and WNK-SPAK/OSR1 pathways and upstream molecules such as ASK3 could be novel therapeutic targets for cancer metastasis.
| DYS REG UL ATI ON OF I ON TR AN S P ORT IN ME TA S TATI C C AN CER CELL S
With regard to volume regulation, net NaCl uptake and net KCl efflux lead to water flow across the plasma membrane during RVI and RVD, respectively. 5 These types of volume regulation locally occur during cell migration. 4 Here, we summarize them, focusing on how they are dysregulated in the volume regulatory systems of metastatic cancer cells.
| Aquaporins
Aquaporins are members of a family of water channels that contains 15 members identified in mammals (AQP0-AQP14). Their main function is to transport water across the membrane in accordance with the osmotic gradient. They play diverse physiological roles, including roles in cell migration, and they have been proposed to also be involved in cancer cell invasion and metastasis. 26, 27 The involvement of AQPs in physiological migration was first reported in 2005. AQP1 knockout mice show impaired angiogenesis because of the low motility of their endothelial cells, and thereby show resistance to tumor growth. 28 Since then, numerous studies have focused on the involvement of AQPs in cell migration, and AQP1, AQP3, AQP4, AQP5, AQP7, and AQP9 have been implicated in physiologically functional cell migration. 4 Furthermore, AQP1, AQP4, AQP5, and AQP9 have been reported to localize to the leading edge during migration. 3, 10, 28, 29 This distribution of AQPs would enable localized water influx and subsequent volume gain, contributing to the protrusion of the leading edge. Among AQPs, AQP1 is the most intensively studied for its role in cancer cell migration. It has been reported to be highly expressed in many types of cancer cells.
Notably, AQP1 shows an increase in its expression in a stage-dependent manner in astrocytoma cells and vasculature. 30 Furthermore, overexpression of AQP1 enhances the migratory and metastatic phenotype of mouse melanoma cells. 31 Thus, AQPs could be responsible for cancer metastasis. With regards to cell volume regulation, RVI after hypertonic shrinkage requires NHE1, which performs net NaCl uptake in cooperation with anion exchanger 2 (AE2). 5 Additionally, NHE1 contributes to solute uptake for protrusion during cell migration. In fact, NHE1 localizes to the leading edge of the cell in the process of protrusion. 33 Moreover, NHE1 is necessary for actin-independent cell migration, which is not attenuated by inhibition of actin polymerization but is suppressed by inhibition of NHE1; interestingly, osmotic shock around cells changes the localization of NHE1 and the direction of migration in this type of cell migration. Therefore, NHE1 is expected to be a novel therapeutic target for cancer metastasis.
| Ion carriers
| Anion exchangers
Anion exchangers belong to the SLC4 family of transporters. They carry out a 1:1 exchange of Cl − and HCO Under conditions of hypertonic cell shrinkage, AE2 mediates net uptake of NaCl in cooperation with NHE1, which evokes subsequent water influx. 5 Anion exchanger 2 localizes to the leading edges of cells during migration, and facilitates protrusion. 33 Moreover, the expression of AE2 in thyroid cancer cells or breast cancer cells is higher than in normal cells. In addition, AE2 expression tends to increase in a stage-dependent manner ( Figure 4A ,B).
Therefore, it is possible that AE2 is responsible for the metastatic phenotype of cancer cells. Because of its ability to increase cell volume, NKCC1 is also involved in cell migration. Initially, it was observed that the NKCC blockers furosemide and bumetanide suppress cell migration in mammals. 36 Afterward, it was revealed that NKCC1 localizes to the leading edges of protrusions under growth factor stimulation. 41 Since these discoveries, the molecular identity of the responsible channel has been intensively studied. 
| Na
| Na + channels
Na + channels, such as voltage-dependent Na + channels (Na v s), epithelial Na + channel (ENaC) and acid-sensing ion channels, play important roles in cell migration. Among them, however, only ENaC has been reported to contribute to cell migration through volume regulation. The ENaC is normally composed of 3 subunits, α-(or δ-), β-, and γ-ENaC. Knockdown of α-, β-, or γ-ENaC subunit impairs RVI after hyperosmotic stress-induced cell shrinkage. 44 The role of ENaC in cell migration is often shown by wound healing assays.
Pharmacological inhibition of ENaC or knockdown of ENaC subunits leads to impaired wound healing after scratching. 45 In addition,
ENaC is abundant at wound edges, which is consistent with the depolarization there. 46 Thus, ENaC could facilitate cell migration by volume gain at the cell front. 4 It is possible that ENaC contributes to cancer cell metastasis.
Adenomatous polyposis coli-mutated mice that develop multiple intestinal neoplasias show high expression of β-and γ-ENaC. 
| Cl − channels
Although K + efflux is an essential component of RVD and cell migration, it must be accompanied by Cl − efflux to maintain electroneutrality. Thus, Cl − channels also play important roles both in RVD after hypotonicity and in rear retraction during cell mi- 
| Volume-regulated anion channels/LRRC8
The existence of VRACs has long been proposed based on observations of Cl − efflux followed by hypoosmotic cell swelling. 5 Through pharmacological inhibition, VRACs have been implicated in cell migration. 49 In addition, VRACs might be locally activated at the rear parts of the cells during cell migration by cholesterol, which actually shows a heterogenous distribution during migration. 50, 51 Although the molecular identity of VRACs has long remained elusive, 2 groups reported in 2014 that the LRRC8 family, especially LRRC8A, is the responsible protein for hypotonicity-induced Cl − currents and RVD. 11, 12 Soon after the identification of its molecular identity, it was reported that LRRC8 senses hypotonicity by sensing intracellular ionic strength. 13 Although there have been few reports about the involvement of LRRC8 in cell migration or cancer metastasis, its involvement is becoming the subject of intense study. Quite recently, it has been reported that knockdown of LRRC8A impairs migration of human colon cancer cells; furthermore, colon cancer tissue shows elevated expression of LRRC8A, and patients with high expression of LRRC8A have higher mortality than those with lower expression. 52 Thus,
VRACs could be novel therapeutic targets for cancer metastasis.
| ClC-3
Although ClC-3 has been reported to be a VRAC, 53 this remains a matter of dispute. 5 However, the necessity of ClC-3 in glioma cell migration has been suggested in some reports showing that knockdown or pharmacological inhibition of ClC-3 suppresses glioma cell migration. 54, 55 Moreover, the expression of ClC-3 in glioma tissue is enhanced in a stage-dependent manner. Thus, ClC-3 has been proposed to be responsible for invasive phenotypes of glioma cells. 54 It could be suggested that ClC-3 contributes to glioma cell migration through volume regulation because invasion through the extracellular space in the brain, which is too narrow for cells to migrate through, requires glioma cells to change their shape and volume by net KCl efflux. 56 Although whether volume decreases mediated by ClC-3 occur in the process of rear retraction remains elusive, it is possible that ClC-3 is locally activated through CaMKII by the intracellular Ca 2+ gradient, which is the lowest at the leading edges and highest at the rear parts of the cells during cell migration, as shown below. 
| Transmembrane protein 16s
Transmembrane protein 16s, also known as anoctamins, are Ca 2+ -activated chloride channels, of which 10 members have been identified (TMEM16A-TMEM16H, TMEM16J, and TMEM16K). Although whether TMEM16s form VRAC is controversial, 57 TMEM16s are necessary for RVD and apoptotic volume decreases. 58 Among the TMEM16s, TMEM16A has been suggested to contribute to cell volume decreases during rear retraction in directional migration. show lower overall survival rates than those with low expression. ), a SAC blocker. Although the molecular identities of SACs in cell migration are still a matter of dispute, they have been proposed to belong to the group of TRP channels. 4 Here, we present 3 TRP channels, TRPM7, TRPC1, and TRPV4, which are major candidate SACs in cell migration.
| Ca
| Transient receptor potential M7
Transient receptor potential M7 is a TRP melastatin channel. It has been reported to be activated by osmotic cell swelling or membrane suction. 14 In addition, TRPM7 is necessary for volume recovery under hypoosmotic stress. 67 Thus, TRPM7 has also been proposed to be one of the SACs. There is substantial evidence that TRPM7 expression positively correlates with cell migration. 4 In particular, TRPM7 produces a very localized Ca 2+ elevation, called a Ca 2+ flicker, during cell migration. 64 Thus, TRPM7 has been suggested to contribute to the protrusion of the leading edge. The expression of TRPM7 is higher in migratory tumor cells than in nonmigratory tumor cells or nontumor cells, and the suppression of TRPM7 attenuates tumor cell migration. 68, 69 Very recently, it was reported that silencing of TRPM7 in ovarian cancer cells decreases metastasis to the lung and prolongs the survival of tumor-bearing mice. 70 Therefore, TRPM7 could be a novel therapeutic target for migratory cancer.
| Transient receptor potential C1
Transient receptor potential C1, which belongs to the TRP canonical channel subfamily, is activated by direct suction of the membrane. 71 It is necessary for directional migration, such as chemotaxis, but is not necessary for basal migration. [72] [73] [74] During cell migration, TRPC1
localizes to the leading edges of cells, which is proposed to contribute to the local elevations in intracellular Ca 2+ at the very front of cells. 72, 74 It could be suggested that TRPC1 plays roles similar to those of TRPM7 in facilitating protrusion through Ca 2+ flickers. 4 Thus, TRPC1 plays an important role in polarization during cell migration by aiding protrusion of the leading edge rather than by aiding rear retraction. 
| Transient receptor potential V4
Transient receptor potential V4 is a member of the TRP vanilloid channels family and is the ortholog of the osmosensitive channel (OSM-9) in Caenorhabditis elegans. 75 Transient receptor potential V4
is activated under hypoosmotic stress and mediates Ca 2+ influx from the extracellular space. 76, 77 It has also been reported that TRPV4
shows sensitivity to mechanical stress caused by direct suction of the membrane. 15 This Ca 2+ influx has been suggested to contribute to RVD because knockdown of TRPV4 leads to impairment of RVD.
78
Given these findings, TRPV4 has been proposed to be one of the SACs. In addition, TRPV4 could also be the SAC in the context of cell migration because cell migration is enhanced by activation of TRPV4, whereas it is suppressed by knockdown of TRPV4. 
| CON CLUS I ON S AND PER S PEC TIVE S
For decades, cell migration has been proposed to be driven mainly by the cytoskeletons. However, recent studies have found that osmotic water flow itself could be the driving force for cell migration. This osmotic water flow is carried out by ion/water transport proteins at the cell surface. In fact, ion/water transport proteins that are involved in cell volume regulation also contribute to cell migration. Cell migration is achieved through a repeated process of protrusion of the leading edge and retraction of the rear part. At the leading edge, net influx of NaCl through NHE1, NKCC1, AE2, and ENaC leads to water influx through AQPs and subsequent volume gain, which facilitates the protrusion. In contrast, net KCl efflux through the IK channel, VRACs, ClC-3, and TMEM16s leads to volume loss, which causes rear retraction ( Figure 2 ). In addition, the intracellular Ca 2+ gradient generated by mechanosensitive Ca 2+ channels orchestrates the localized activity of ion transport proteins, although there is no consensus on the molecular identities of these channels in the context of cell migration.
These ion/water transport proteins often have enhanced activity or expression in metastatic cancer cells. In addition, inhibition of these transport proteins leads to impaired cancer cell migration.
Thus, ion/water transport proteins have the potential to be novel therapeutic targets. In fact, the Cl − channel inhibitor chlorotoxin has been the subject of much interest as an anticancer drug. Moreover, 
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